Lilly’s quarterly results Thursday, combined with Novo Nordisk’s unsolicited offer for a startup, confirm the $72 billion ...
Texas AG Ken Paxton accuses J&J and Kenvue of hiding Tylenol's autism risks for pregnant women in new lawsuit.
Takeda tightened its pipeline in the third quarter. Innovent Biologics reported a head-to-head win against semaglutide in a Chinese phase 3 trial. | Takeda tightened its pipeline in the third quarter.
While the company’s sales outlook was otherwise rosy, Merck took sales hits on Gardisil, Proquad, Varivax and Vaxneuvance.
BridgeBio Pharma, Inc.'s Attruby (Acoramidis) delivers early, durable reductions in cumulative cardiovascular events. Learn ...
with Delaware courts potentially deciding whether competitive concerns or contractual commitments prevail. The post Pfizer ...
In a Truth Social post late Thursday, Trump said that any branded or patented pharmaceutical products brought into the U.S.
President Xi Jinping’s stranglehold on rare earths will give China unprecedented leverage to win concessions from the US ...
Liminatus Pharma, Inc. (NASDAQ: LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered into a Memorandum ...
Three pharma companies that have delivered the highest average 5-year ROCE are all into manufacturing the same type of ...
Shares in Mayne Pharma plunged by nearly a third on Friday after it emerged that Australia's treasurer was considering blocking a A$672 million ($435 million) offer for the company from now-reluctant ...
MarketBeat on MSN
How Royalty Pharma Prints Cash Without Biotech's Biggest Risks
Investing in biotechnology often feels like navigating a minefield. A single failed clinical trial can decimate a stock, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback